These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1048 related articles for article (PubMed ID: 16427212)
1. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Sedlis A; Bundy BN; Rotman MZ; Lentz SS; Muderspach LI; Zaino RJ Gynecol Oncol; 1999 May; 73(2):177-83. PubMed ID: 10329031 [TBL] [Abstract][Full Text] [Related]
3. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Monk BJ; Wang J; Im S; Stock RJ; Peters WA; Liu PY; Barrett RJ; Berek JS; Souhami L; Grigsby PW; Gordon W; Alberts DS; ; ; Gynecol Oncol; 2005 Mar; 96(3):721-8. PubMed ID: 15721417 [TBL] [Abstract][Full Text] [Related]
4. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863 [TBL] [Abstract][Full Text] [Related]
5. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872 [TBL] [Abstract][Full Text] [Related]
6. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer. Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855 [TBL] [Abstract][Full Text] [Related]
7. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643 [TBL] [Abstract][Full Text] [Related]
11. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Coleman RL; Keeney ED; Freedman RS; Burke TW; Eifel PJ; Rutledge FN Gynecol Oncol; 1994 Oct; 55(1):29-35. PubMed ID: 7959262 [TBL] [Abstract][Full Text] [Related]
12. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284 [TBL] [Abstract][Full Text] [Related]
13. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery. Hille A; Weiss E; Hess CF Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA. Kornovski Y; Gorchev G J BUON; 2006; 11(3):291-7. PubMed ID: 17309152 [TBL] [Abstract][Full Text] [Related]
16. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy. Kornovski Y; Gorchev G J BUON; 2007; 12(1):57-63. PubMed ID: 17436403 [TBL] [Abstract][Full Text] [Related]
17. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome. Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729 [TBL] [Abstract][Full Text] [Related]
18. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837 [TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis. Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]